Structural basis for the intracellular regulation of ferritin degradation.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
07 May 2024
Historique:
received: 14 11 2023
accepted: 19 04 2024
medline: 8 5 2024
pubmed: 8 5 2024
entrez: 7 5 2024
Statut: epublish

Résumé

The interaction between nuclear receptor coactivator 4 (NCOA4) and the iron storage protein ferritin is a crucial component of cellular iron homeostasis. The binding of NCOA4 to the FTH1 subunits of ferritin initiates ferritinophagy-a ferritin-specific autophagic pathway leading to the release of the iron stored inside ferritin. The dysregulation of NCOA4 is associated with several diseases, including neurodegenerative disorders and cancer, highlighting the NCOA4-ferritin interface as a prime target for drug development. Here, we present the cryo-EM structure of the NCOA4-FTH1 interface, resolving 16 amino acids of NCOA4 that are crucial for the interaction. The characterization of mutants, designed to modulate the NCOA4-FTH1 interaction, is used to validate the significance of the different features of the binding site. Our results explain the role of the large solvent-exposed hydrophobic patch found on the surface of FTH1 and pave the way for the rational development of ferritinophagy modulators.

Identifiants

pubmed: 38714719
doi: 10.1038/s41467-024-48151-1
pii: 10.1038/s41467-024-48151-1
doi:

Substances chimiques

Ferritins 9007-73-2
FTH1 protein, human EC 1.-
Nuclear Receptor Coactivators 0
NCOA4 protein, human 0
Iron E1UOL152H7
Oxidoreductases EC 1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3802

Subventions

Organisme : Israel Science Foundation (ISF)
ID : 364/20
Organisme : United States - Israel Binational Science Foundation (BSF)
ID : 2022614
Organisme : National Science Foundation (NSF)
ID : 2231900
Organisme : U.S. Department of Health & Human Services | National Institutes of Health (NIH)
ID : R01-DK124384

Informations de copyright

© 2024. The Author(s).

Références

Pantopoulos, K., Porwal, S. K., Tartakoff, A. & Devireddy, L. Mechanisms of mammalian iron homeostasis. Biochemistry 51, 5705–5724 (2012).
doi: 10.1021/bi300752r pubmed: 22703180
Dixon, S. J. & Stockwell, B. R. The role of iron and reactive oxygen species in cell death. Nat. Chem. Biol. 10, 9–17 (2014).
doi: 10.1038/nchembio.1416 pubmed: 24346035
Galy, B., Conrad, M. & Muckenthaler, M. Mechanisms controlling cellular and systemic iron homeostasis. Nat. Rev. Mol. Cell Biol. 25, 133–155 (2024).
Arosio, P., Ingrassia, R. & Cavadini, P. Ferritins: A family of molecules for iron storage, antioxidation and more. Biochim. et Biophys. Acta (BBA) - Gen.Subj. 1790, 589–599 (2009).
doi: 10.1016/j.bbagen.2008.09.004
Radisky, D. C. & Kaplan, J. Iron in cytosolic ferritin can be recycled through lysosomal degradation in human fibroblasts. Biochem. J. 336, 201–205 (1998).
doi: 10.1042/bj3360201 pubmed: 9806901 pmcid: 1219858
Asano, T. et al. Distinct mechanisms of ferritin delivery to lysosomes in iron-depleted and iron-replete cells. Mol. Cell Biol. 31, 2040–2052 (2011).
doi: 10.1128/MCB.01437-10 pubmed: 21444722 pmcid: 3133360
Mancias, J. D., Wang, X., Gygi, S. P., Harper, J. W. & Kimmelman, A. C. Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature 509, 105–109 (2014).
doi: 10.1038/nature13148 pubmed: 24695223 pmcid: 4180099
Dowdle, W. E. et al. Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo. Nat. Cell Biol. 16, 1069–1079 (2014).
doi: 10.1038/ncb3053 pubmed: 25327288
Ohshima, T., Yamamoto, H., Sakamaki, Y., Saito, C. & Mizushima, N. NCOA4 drives ferritin phase separation to facilitate macroferritinophagy and microferritinophagy. J. Cell Biol. 221, e202203102 (2022).
doi: 10.1083/jcb.202203102 pubmed: 36066504 pmcid: 9452830
Mancias, J. D. et al. Ferritinophagy via NCOA4 is required for erythropoiesis and is regulated by iron dependent HERC2-mediated proteolysis. Elife 4, e10308 (2015).
Srivastava, A. K. et al. Thermodynamic and kinetic studies of the interaction of Nuclear Receptor Coactivator-4 (NCOA4) with human ferritin. Biochemistry 59, 2707–2717 (2020).
doi: 10.1021/acs.biochem.0c00246 pubmed: 32608971
Kuno, S., Fujita, H., Tanaka, Y., Ogra, Y. & Iwai, K. Iron‐induced NCOA4 condensation regulates ferritin fate and iron homeostasis. EMBO Rep. 23, e54278 (2022).
doi: 10.15252/embr.202154278 pubmed: 35318808 pmcid: 9066066
Bou-Abdallah, F. The iron redox and hydrolysis chemistry of the ferritins. Biochim. et Biophys. Acta (BBA) - Gen. Subj. 1800, 719–731 (2010).
doi: 10.1016/j.bbagen.2010.03.021
Ochoa, D. et al. The functional landscape of the human phosphoproteome. Nat. Biotechnol. 38, 365–373 (2020).
doi: 10.1038/s41587-019-0344-3 pubmed: 31819260
Santana-Codina, N. et al. NCOA4 maintains murine erythropoiesis via cell autonomous and non-autonomous mechanisms. Haematologica 104, 1342–1354 (2019).
doi: 10.3324/haematol.2018.204123 pubmed: 30630985 pmcid: 6601094
Li, X. et al. NCOA4 is regulated by HIF and mediates mobilization of murine hepatic iron stores after blood loss. Blood 136, 2691–2702 (2020).
pubmed: 32659785 pmcid: 7735158
Yan, H. et al. Ferroptosis: mechanisms and links with diseases. Signal Transduct Target Ther. 6, 49 (2021).
doi: 10.1038/s41392-020-00428-9 pubmed: 33536413 pmcid: 7858612
Ito, J. et al. Iron derived from autophagy-mediated ferritin degradation induces cardiomyocyte death and heart failure in mice. Elife 10, e62174 (2021).
Chen, Y. et al. Ferroptosis: A novel therapeutic target for ischemia-reperfusion injury. Front. Cell Dev. Biol. 9, 688605 (2021).
Gao, M. et al. Ferroptosis is an autophagic cell death process. Cell Res 26, 1021–1032 (2016).
doi: 10.1038/cr.2016.95 pubmed: 27514700 pmcid: 5034113
Yoshida, M. et al. Involvement of cigarette smoke-induced epithelial cell ferroptosis in COPD pathogenesis. Nat. Commun. 10, 1–14 (2019).
doi: 10.1038/s41467-019-10991-7
Santana-Codina, N. et al. NCOA4-mediated ferritinophagy is a pancreatic cancer dependency via maintenance of iron bioavailability for iron–sulfur cluster proteins. Cancer Discov. 12, 2180–2197 (2022).
doi: 10.1158/2159-8290.CD-22-0043 pubmed: 35771492 pmcid: 9437572
Ravichandran, M. et al. Coordinated transcriptional and catabolic programs support iron-dependent adaptation to RAS–MAPK pathway inhibition in pancreatic cancer. Cancer Discov. 12, 2198–2219 (2022).
doi: 10.1158/2159-8290.CD-22-0044 pubmed: 35771494 pmcid: 9444964
Dai, Y. et al. Mycobacterium tuberculosis hijacks host TRIM21- and NCOA4-dependent ferritinophagy to enhance intracellular growth. J. Clin. Invest. 133, e159941 (2023).
Fang, Y. et al. Inhibiting Ferroptosis through Disrupting the NCOA4-FTH1 Interaction: A New Mechanism of Action. ACS Cent. Sci. 7, 980–989 (2021).
Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. Elife 7, e42166 (2018).
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486–501 (2010).
doi: 10.1107/S0907444910007493 pubmed: 20383002 pmcid: 2852313
Casañal, A., Lohkamp, B. & Emsley, P. Current developments in Coot for macromolecular model building of Electron Cryo‐microscopy and Crystallographic Data. Protein Sci. 29, 1055–1064 (2020).
doi: 10.1002/pro.3791
Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. D Struct. Biol. 74, 531–544 (2018).
doi: 10.1107/S2059798318006551 pubmed: 29872004 pmcid: 6096492
Zhang, K., Pintilie, G. D., Li, S., Schmid, M. F. & Chiu, W. Resolving individual atoms of protein complex by cryo-electron microscopy. Cell Res. 30, 1136–1139 (2020).
doi: 10.1038/s41422-020-00432-2 pubmed: 33139928
Molecular Lipophilicity Potential. https://www.cgl.ucsf.edu/chimera/data/mlp-sep2016/index.html#update .
Ghose, A. K., Viswanadhan, V. N. & Wendoloski, J. J. Prediction of hydrophobic (lipophilic) properties of small organic molecules using fragmental methods: An analysis of ALOGP and CLOGP methods. J. Phys. Chem. A 102, 3762–3772 (1998).
doi: 10.1021/jp980230o

Auteurs

Fabian Hoelzgen (F)

The Kreitman School of Advanced Graduate Studies, Marcus Family Campus, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Department of Life Sciences, Marcus Family Campus, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Thuy T P Nguyen (TTP)

Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

Elina Klukin (E)

Department of Life Sciences, Marcus Family Campus, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Mohamed Boumaiza (M)

Department of Chemistry, State University of New York at Potsdam (SUNY Potsdam), Potsdam, NY, USA.

Ayush K Srivastava (AK)

Department of Chemistry, State University of New York at Potsdam (SUNY Potsdam), Potsdam, NY, USA.

Elizabeth Y Kim (EY)

Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

Ran Zalk (R)

Ilse Katz Institute for Nanoscale Science & Technology, Marcus Family Campus, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Anat Shahar (A)

Ilse Katz Institute for Nanoscale Science & Technology, Marcus Family Campus, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Sagit Cohen-Schwartz (S)

The National Institute for Biotechnology in the Negev - NIBN, Marcus Family Campus, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Esther G Meyron-Holtz (EG)

Faculty of Biotechnology and Food Engineering, Technion, Haifa, Israel.

Fadi Bou-Abdallah (F)

Department of Chemistry, State University of New York at Potsdam (SUNY Potsdam), Potsdam, NY, USA.

Joseph D Mancias (JD)

Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Joseph_Mancias@dfci.harvard.edu.
Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Joseph_Mancias@dfci.harvard.edu.

Gabriel A Frank (GA)

Department of Life Sciences, Marcus Family Campus, Ben-Gurion University of the Negev, Beer-Sheva, Israel. frankg@bgu.ac.il.
Ilse Katz Institute for Nanoscale Science & Technology, Marcus Family Campus, Ben-Gurion University of the Negev, Beer-Sheva, Israel. frankg@bgu.ac.il.
The National Institute for Biotechnology in the Negev - NIBN, Marcus Family Campus, Ben-Gurion University of the Negev, Beer-Sheva, Israel. frankg@bgu.ac.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH